• KOL
    • KOLs Community
    • Parathyroid
    • Parathyroid Cancer
    • Klausmartin H Schulte
    • KlausMartin H Schulte

      KlausMartin H Schulte

      King's College Hospital NHS Trust, London, UK | Medical School, Australian National University, Canberra, Australian Capital Territory, Australia | Medical School, College of ...

       

       

      KOL Resume for KlausMartin H Schulte

      Year
      2022

      King's College Hospital NHS Trust, London, UK

      2021

      Medical School, Australian National University, Canberra, Australian Capital Territory, Australia

      2020

      Medical School, College of Health and Medicine, Australian National University, Canberra, Australia

      Department of Endocrine Surgery, King's College Hospital NHS Foundation Trust, London, UK.

      2019

      Department of Endocrine Surgery, King's College Hospital NHS Foundation Trust, Brixton, London, UK.

      2018

      Department of Radiology, King’s College Hospital NHS Foundation Trust London, London, UK

      2017

      Department of Surgery, King’s College Hospital, NHS Foundation Trust, London, UK

      2016

      Department of Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia

      2014

      Klaus-Martin Schulte MD FRCS is a Consultant Surgeon in the Department of Endocrine Surgery at King's College Hospital, London, UK. Conflicts of interest: none declared

      John Curtin School of Medical Research Australian National University Department of Surgery Canberra ACT Australia

      King's College Hospital and King's Health Partners Department of Endocrine Surgery London UK

      From the *Clinical PET Centre, Division of Imaging Sciences, King’s College London; †Department of Endocrine Surgery, King’s College Hospital; and ‡Department of Endocrine Surgery, Guy’s & St Thomas’ Hospital, London, United Kingdom.

      2013

      King's College Hospital – Endocrinology London UK

      2012

      Department of Endocrine Surgery, King's College Hospital, Denmark Hill, London, SE5 9RS, UK

      King's College London

      2011

      Major Trauma Centre, King's College Hospital NHS Foundation Trust, King's Health Partners Academic Health Sciences Centre, Denmark Hill, London, SE5 9RS, UK

      Department of Endocrine Surgery, King's College Hospital, King's Health Partners, London, United Kingdom

      King’s Health Partners

      2010

      Department of Endocrine Surgery, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom.

      Surgery, King’s College London, London, UK

      2009

      Department of General Surgery, King's College Hospital, Denmark Hill, London, UK

      2008

      Consultant in Endocrine and General Surgery, Department of Endocrine Surgery, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom Honorary Senior Lecturer of Surgery, King's College London

      2007

      Department of Endocrine Surgery, King's College Hospital, London, United Kingdom

      2006

      Department of General Surgery (Breast/Endocrine),1King's College Hospital, Denmark Hill, London, UK, GKT Medical School,2London Bridge, London, UK

      2005

      Department of General and Trauma Surgery, Heinrich-Heine University, Düsseldorf, Germany

      2004

      Department of General and Trauma Surgery, Heinrich-Heine University, Moorenstrasse 5, 40225, Düsseldorf, Germany

      Klinik für Allgemein- und Unfallchirurgie, Universitätsklinikum Düsseldorf

      2003

      Heinrich-Heine-Universität, Düsseldorf, Germany.

      Department of Trauma Surgery, Ernst-Moritz-Arndt-University of Greifswald and Unfallkrankenhaus, Berlin, Germany; and Clinic for General Surgery and Trauma Surgery, Heinrich-Heine-University, Düsseldorf, Germany

      2002

      Department of General and Trauma Surgery, Heinrich Heine University (K.-M.S., H.-D.R.), Düsseldorf, Germany

      2001

      Clinic for General Surgery, Heinrich-Heine-Universität Düsseldorf, Germany

      Klinik für Allgemein- und Unfallchirurgie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf.

      From the Department of Nephrology and Transplantation, Henri Mondor Teaching Hospital, Creteil, France.

      2000

      Klinik für Allgemeine und Unfallchirurgie, Heinrich-Heine-Universität, Moorenstrasse 5, D-40225 Düsseldorf, Germany, DE

      Clinic for Vascular Surgery, University Clinics, Heinrich-Heine-University, Düsseldorf, Germany

      1999

      Klinik für Allgemeine Chirurgie und Unfallchirurgie, Medizinische Einrichtungen, Heinrich-Heine-University, Moorenstr. 5, D-40225 Düsseldorf, Germany, Germany

      Clinic of General Surgery, Heinrich-Heine University, Düsseldorf

      1998

      Dept. for General and Trauma Surgery, Heinrich Heine University, Düsseldorf, Germany.

      1996

      Department of General Surgery, Heinrich-Heine-University, Düsseldorf, Germany.

      1992

      Service de Néphrologic, Hôpital Henri Mondor, Créteil, France

      1987

      Division of Gastroenterology, Department of Medicine, University of Essen, and, Department of Clinical Research I, Pharmaceutical Research Center, Bayer AG, Wuppertal-Elberfeld, FRG

       

       

      KlausMartin H Schulte: Influence Statistics

      Sample of concepts for which KlausMartin H Schulte is among the top experts in the world.
      Concept World rank
      vascularity npv #1
      malignancy parathyroid lesions #1
      hiv patients class #1
      00001 unicentric #1
      disease χ² #1
      positron castleman #1
      centricity pathology type #1
      972 published patients #1
      periadrenal hyaline #1
      parathyroid cancer recommendations #1
      404 published cases #1
      radical retroperitonectomy #1
      involvement fulltext review #1
      objectivenearly #1
      parathyroid cancer surgery #1
      disease unicentric disease #1
      calcification ppv #1
      00001 multicentric #1
      surgery castlemans disease #1
      1791 citations #1
      incoherent evidence #1
      retroperitoneal unicentric #1
      narrow followup #1
      unifocal unicentric disease #1
      focus unicentric #1
      resective debulking #1
      focus multicentric #1
      1538 allele #2
      heterogenous echogenicity #2
      alk41 receptors #2
      histological disease prognosis #2
      calcification capsular thickening #2
      management parathyroid cancer #2
      patients oncological resection #2
      tgfbeta1 activins adenocarcinoma #2
      thickening infiltrative #2
      hspa1l hspa1l genotype #2
      review preoperative diagnosis #2
      rare primary disease #2
      capsular thickening 15 #2
      vascularity capsular thickening #2
      beta1 reversal #2
      heterogeneous echogenicity vascularity #2
      hspa1l 2437 allele #2
      shape 168 #2
      calcification capsular #2
      genotypes hspa1b #2
      vascularity reviewed #2
      isoforms alk4 #2
      genotypes hspa1b hspa1l #2

       

      Prominent publications by KlausMartin H Schulte

      KOL-Index: 11540

      BACKGROUND & AIMS: Lysophosphatidic acid (LPA) is assumed to play an important role in the modulation of injury and tissue repair in nonepithelial tissues. The effects of LPA on intestinal epithelial wound repair in vitro and in vivo were characterized.

      METHODS: Effects of LPA on intestinal epithelial restitution and proliferation were assessed by using an in vitro wounding model with confluent intestinal epithelial cell line 6 (IEC-6) monolayers and colorimetric thiazolyl blue (MTT) ...

      Known for Wound Healing | Intestinal Epithelial | Lysophosphatidic Acid | Effects Lpa | Colitis Rats
      KOL-Index: 10424

      BACKGROUND: Papillary thyroid cancer (PTC) is a common endocrine cancer and commonly presents with lymph node (LN) metastases. The role of surgical removal of the central cervical LN compartment is poorly defined. There are no prospective randomized controlled trials addressing the relevance to the extent of the initial surgical approach.

      DESIGN AND METHODS: A systematic review of studies of patients with PTC undergoing either prophylactic or therapeutic lymphadenectomy of the central ...

      Known for Lymph Node | Papillary Thyroid Cancer | Patients Ptc | Central Compartment | Prophylactic Removal
      KOL-Index: 10390

      BACKGROUND & AIMS: Although bone loss and osteoporosis are well-known long-term sequelae of inflammatory bowel disease (IBD), the risk factors for increased bone loss have not been identified. Balances of pro- and anti-inflammatory cytokines influence mechanisms of both chronic inflammation and bone resorption. The aim of this study was to identify genetic risk factors for rapid bone loss in IBD patients as a model of disease- and inflammation-associated bone loss.

      METHODS: Multiple ...

      Known for Bone Loss | Genetic Factors | Inflammatory Bowel | Ibd Patients | Heat Shock
      KOL-Index: 9430

      The immune system plays an instrumental role in obesity and insulin resistance. Here, we unravel the role of the costimulatory molecule CD40 and its signaling intermediates, TNF receptor-associated factors (TRAFs), in diet-induced obesity (DIO). Although not exhibiting increased weight gain, male CD40(-/-) mice in DIO displayed worsened insulin resistance, compared with wild-type mice. This worsening was associated with excessive inflammation of adipose tissue (AT), characterized by ...

      Known for Insulin Resistance | Cd40 Mice | Therapeutic Target | Traf6 Signaling | Mhcii Cells
      KOL-Index: 9418

      Lysophosphatidic acid (LPA) is a small lipid mediator with pleiotropic biological activities, e.g., the regulation of cellular proliferation and various aspects of cellular physiology. Signal transduction is achieved by binding to 2 high-affinity receptors, EDG2 and EDG4, and a group of low-affinity receptors, EDG1-7, all belonging to the superfamily of G protein-coupled receptors. We examined the growth-regulatory effects of LPA in primary cultures of 8 goiters and 1 papillary thyroid ...

      Known for Lysophosphatidic Acid | Messenger Receptors | Human Thyroid | Mrna Expression | Receptor Edg4
      KOL-Index: 8376

      OBJECTIVE: To examine the influence of genetic variations in heat shock proteins on trauma outcome.

      DESIGN: Prospective, noninterventional, single-center study.

      SETTING: Level I trauma center.

      SUBJECTS: Eighty consecutive severe multiple trauma patients.

      INTERVENTIONS: None.

      MEASUREMENTS AND MAIN RESULTS: Plasma concentrations of interleukin-6 and tumor necrosis factor-alpha were measured over a 5-day course by chemiluminescence-immunoassay. The genotypes of the polymorphisms HSPA1B ...

      Known for Heat Shock | Genetic Variations | Multiple Trauma | Allele Frequency | Tumor Necrosis Factoralpha
      KOL-Index: 8055

      BACKGROUND: Papillary thyroid cancer (PTC) is a common endocrine cancer and frequently presents with lymph node (LN) metastases. The frequency of LN metastases in the lateral compartment and their surgical removal are poorly defined. There are no prospective randomised controlled trials addressing an eventual outcome difference relating to the extent of the initial surgical approach. The aim of this study was to define the extent of lateral LN involvement and the role of imaging in ...

      Known for Thyroid Cancer | Lymph Node | Lateral Cervical | Patients Ptc | Papillary Humans
      KOL-Index: 7221

      Dysbalance in the immune system is perceived as a major factor for adverse outcome after trauma. Transforming growth factor-beta1 (TGF-beta1) is a multifunctional cytokine that regulates proliferation, differentiation of cells, wound healing, and angiogenesis. The influence of TGF-beta1 on trauma patients outcome is still unclear. Injury patterns and clinical outcome parameters of 99 consecutive patients with life-threatening injury and an injury severity score (ISS) > 15 were assessed ...

      Known for Transforming Growth | Major Trauma | Tgf Beta1 | Patients Sepsis | Plasma Levels
      KOL-Index: 7207

      BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignancy, with an annual incidence of 1 or 2 cases per million. Biochemical diagnosis is challenging because up to two-thirds of the carcinomas are biochemically silent, resulting from de facto enzyme deficiencies in steroid hormone biosynthesis. Urine steroid profiling by GC-MS is an effective diagnostic test for ACC because of its capacity to detect and quantify the increased metabolites of steroid pathway synthetic intermediates. ...

      Known for Adrenocortical Carcinoma Acc | Serum Steroid | Biochemical Diagnosis | Rare Malignancy | Lcms Method
      KOL-Index: 7125

      Based on several case-control studies, it has been estimated that familial aggregation and genetic susceptibility play a role in up to 10% of patients with pancreatic cancer, although conclusive epidemiologic data are still lacking. Therefore, we evaluated the prevalence of familial pancreatic cancer and differences to its sporadic form in a prospective multicenter trial. A total of 479 consecutive patients with newly diagnosed, histologically confirmed adenocarcinoma of the pancreas ...

      Known for Pancreatic Cancer | Aged Odds | Familial Sporadic | Genetic Predisposition | Germany Humans
      KOL-Index: 6999

      AIM: To investigate the role of coding region mutation and promoter hypermethylation of TP53 in adrenocortical cancer formation.

      METHODS: Twenty sporadic adrenocortical cancers (ACCs) and five normal adrenal tissue samples were available for analysis. Coding region mutation of TP53 in 20 ACCs was examined by polymerase chain amplification using intronic primers for exons 2-11 and direct sequencing of the product. In 10 ACCs and five normal adrenal tissue specimens, methylation of the 16 ...

      Known for Methylation Analysis | Tp53 Mutation | P53 Humans | Female Genes | Direct Sequencing
      KOL-Index: 6828

      A dysbalanced immune response is thought to account for a substantial part of the morbidity and mortality after severe trauma. The cytokine interleukin-10 (IL-10) suppresses the transcription of proinflammatory cytokines, mainly in macrophages and monocytes. The objectives of this prospective study in a level I trauma center in Germany were to examine the distribution of IL-10 promoter polymorphisms in a cohort of severely injured patients, to measure IL-10 cytokine levels and relate ...

      Known for Major Trauma | Multiple Organ | Promoter Polymorphisms | Il10 Genotype | Proinflammatory Cytokines

      Key People For Parathyroid Cancer

      Top KOLs in the world
      #1
      Takao OBARA
      parathyroid carcinoma men1 gene thyroid follicles
      #2
      Orlo Herrick Clark
      thyroid cancer laparoscopic adrenalectomy cell lines
      #3
      Lars‐Ove Farnebo
      primary hyperparathyroidism plasma catecholamines men1 gene
      #4
      Kerstin Sandelin
      breast cancer body image men1 gene
      #5
      Lars E Grimelius
      parathyroid glands endocrine cells thyroid cancer
      #6
      John Paul Bilezikian
      primary hyperparathyroidism parathyroid hormone postmenopausal women

      KlausMartin H Schulte:Expert Impact

      Concepts for whichKlausMartin H Schultehas direct influence:Parathyroid cancer,  Bone loss,  Thyroid cancer,  Renal transplantation,  Cmv disease,  Human thyroid,  Lymph node,  Nodal metastases.

      KlausMartin H Schulte:KOL impact

      Concepts related to the work of other authors for whichfor which KlausMartin H Schulte has influence:Parathyroid carcinoma,  Castleman disease,  Lysophosphatidic acid,  Pancreatic cancer,  Adrenocortical tumors,  Papillary thyroid,  Lymph node.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      King's College Hospital NHS Trust, London, UK | Medical School, Australian National University, Canberra, Australian Capital Territory, Australia | Medical School, College of Health and Medicine, Australian National University, Canberra, Australia |

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.